Skip to content
Buy This GLP
← Research
Evidence

Hip Fracture Surgery in GLP-1 Users: Complications Against Three BMI Groups

One hospital registry found fewer in-hospital complications among patients with obesity who were already using a GLP-1 before a hip fracture.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
Overall complications, 58 patients per groupobesity, on a GLP-122.41%normal weight55.17%overweight51.72%obesity, no GLP-160.34%One hospital registry. Groups were matched, not randomized.

People with obesity who had been on a GLP-1 medicine for at least six months had fewer in-hospital complications after hip fracture surgery in one hospital registry study. The study compared patient records, so it could not determine whether the medicine caused the difference [1].

What the study compared

Our guide to GLP-1 use and hip fracture risk covers whether fractures occur. This study looked at what happened after a fracture. The researchers used a prospective registry from a single institution covering 2014–2024. They matched patients by age, fracture pattern and other health conditions [1].

Complications and readmissions after surgery

Among patients with obesity, the overall in-hospital complication rate was 22.41% with GLP-1 use, compared with 60.34% without it (P < 0.001 across the four groups). The rates were 55.17% at normal weight and 51.72% with overweight. Minor complication rates were 17.24% with GLP-1 use, 48.28% with obesity and no GLP-1 use, 37.93% at normal weight and 51.72% with overweight. The differences across the four groups were statistically significant for both measures [1].

The study reported higher readmission rates in the group with obesity that did not use a GLP-1: 17.24% at 30 days and 24.14% at 90 days. The analysis did not detect significant differences in major complications or implant failure [1].

Our guide to GLP-1 medicines before surgery addresses medication planning for procedures. This registry study recorded prior use at the time of injury and did not test starting or stopping treatment around surgery.

Frequently asked

Does being on a GLP-1 make hip fracture surgery safer?
The registry found fewer overall in-hospital complications in people with obesity already using a GLP-1. The study could not determine whether the medicine caused that difference.
Which outcomes differed?
The study detected differences in minor complications and readmissions. It did not detect significant differences in major complications or implant failure.
How big was the study?
It included 232 patients at one institution, with 58 in each of four groups. The authors classified it as Level III evidence.

Sources

  1. [1] Goldstein AR, Olson D, Leucht P, Tejwani N, Ganta A, Konda S, Egol KA (2025). Slimming the risks: GLP-1 receptor agonist therapy may reduce in-hospital complications and hospital readmission rates in patients with obesity undergoing hip fracture surgery European Journal of Orthopaedic Surgery & Traumatology. PMID 40892123

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence